Results 91 to 100 of about 2,233 (157)

Tezepelumab attenuates exertional symptom burden in severe asthma: insights from a real-world cohort. [PDF]

Front Allergy
Stoshikj S, Marth K, Boryshchuk D, Ristl R, Renner A, Bal C, Patocka K, Pohl W, Vonbank K, Idzko M.   +9 more
europepmc   +1 more source

Control first, tolerance second: biologics as enablers of allergen immunotherapy in severe allergic asthma. [PDF]

Front Allergy
Jentzsch B, Hoheisel A, Gashynova K, Fähndrich S, Frye BC, Alvarado Castillo JA, Müller S, Cherrez-Ojeda I, Stolz D.   +8 more
europepmc   +1 more source

Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system. [PDF]

Pediatr Allergy Immunol
Zhang Y, Liu Y, Chen L, Chen Y, Zheng X.
europepmc   +1 more source

Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology. [PDF]

Front Pharmacol
Mansour GK, Kumar S, Sukkarieh HH.
europepmc   +1 more source

Remission of Eosinophilic Otitis Media With Tezepelumab

Journal of Investigational Allergology and Clinical Immunology
Diana Betancor, William Aragonés Sanzen-Baker, Virginia Vasallo, Jaime Bernaola, Jesica Santillan, Jose Villacampa, Joaquin Sastre   +6 more
openaire   +1 more source

Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma. [PDF]

J Allergy Clin Immunol Glob
Matsuno O, Kawashima K, Hanada Y, Wibowo T, Ishida Y, Ogata A.   +5 more
europepmc   +1 more source

Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]

BMJ Med
Tejwani V, Siddharthan T, Majumdar U, Hatipoğlu U, Hanania NA.   +4 more
europepmc   +1 more source

Impact of Biologics on Oscillometry Defined Small Airway Dysfunction in Uncontrolled Asthma. [PDF]

Clin Exp Allergy
Greig R, Suter P, Chan R, Lipworth B.
europepmc   +1 more source

One size does not fit all: uncontrolled T2 inflammation on tezepelumab-a case series. [PDF]

Allergy Asthma Clin Immunol
Tardif A, Boulay ME, Côté A, Godbout K.   +3 more
europepmc   +1 more source

Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma. [PDF]

Clin Exp Allergy
Marriott H, Adatia A, Moitra S, Lacy P.
europepmc   +1 more source